Clinical Trial Update: A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes [Phase 1, Phase 2]

View source ↗

Summary

The document provides a status update on a Phase 1/2 study of PBFT02 for frontotemporal dementia in patients with GRN or C9ORF72 mutations, which is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Drugs mentioned

• PBFT02

Snippet

Sponsor: Passage Bio, Inc. | Conditions: Frontotemporal Dementia, FTD | Phase 1, Phase 2 | Status: RECRUITING